Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection

Balkan Med J. 2021 Mar;38(2):141-142. doi: 10.4274/balkanmedj.galenos.2020.2020.9.106.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • COVID-19 / complications*
  • COVID-19 / diagnosis
  • COVID-19 Drug Treatment
  • Follow-Up Studies
  • Humans
  • Lymphoma, Mantle-Cell / complications*
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / pathology
  • Male
  • Piperidines / therapeutic use*
  • Recurrence
  • Retreatment
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Piperidines
  • ibrutinib
  • Adenine